Guidance for industry [electronic resource] : S1C(R2) dose selection for carcinogenicity studies.
Imprint
Silver Spring, MD : U.S. Dept. of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research ; [Rockville, MD] : Center for Biologics Evaluation and Research, [2008]
